|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current assets | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total Current Assets | |||||||
| Investments held in Trust Account | |||||||
| TOTAL ASSETS | |||||||
| Liabilities | |||||||
| Current liabilities | |||||||
| Accrued expenses | |||||||
| Income taxes payable | |||||||
| Total Current Liabilities | |||||||
| Deferred underwriting fee payable | |||||||
| Derivative warrant liabilities | |||||||
| Total Liabilities | |||||||
| Class A common stock subject to possible redemption; $0.0001 par value, 500,000,000 shares authorized; 40,000,000 shares at a redemption value of $10.04 and $10.00 per share as of September 30, 2022, and December 31, 2021, respectively | |||||||
| Stockholders’ Deficit | |||||||
| Class A common stock, $0.0001 par value; 500,000,000 shares authorized; 4,267,958 issued and outstanding (excluding 35,732,042 subject to possible redemption) as of June 30, 2021 and no issued and outstanding at December 31, 2020. | |||||||
| Class B common stock, $0.0001 par value; 50,000,000 shares authorized; 10,000,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021 | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Stockholders’ Deficit | |||||||
| TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT |
Loading...